Inhibitory effect of capsaicin on B16-F10 melanoma cell migration via the phosphatidylinositol 3-kinase/Akt/Rac1 signal pathway
Capsaicin ( trans -8-methyl- N -vanillyl-6-nonenamide), the major pungent ingredient of red pepper, has been reported to possess anti-carcinogenic and anti-mutagenic activities. In this study, the anti-migration activity of capsaicin on highly metastatic B16-F10 melanoma cells was investigated. Caps...
Saved in:
Published in | Experimental & molecular medicine Vol. 40; no. 5; pp. 486 - 494 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
31.10.2008
Springer Nature B.V Korean Society of Medical Biochemistry and Molecular Biology 생화학분자생물학회 |
Subjects | |
Online Access | Get full text |
ISSN | 1226-3613 2092-6413 |
DOI | 10.3858/emm.2008.40.5.486 |
Cover
Summary: | Capsaicin (
trans
-8-methyl-
N
-vanillyl-6-nonenamide), the major pungent ingredient of red pepper, has been reported to possess anti-carcinogenic and anti-mutagenic activities. In this study, the anti-migration activity of capsaicin on highly metastatic B16-F10 melanoma cells was investigated. Capsaicin significantly inhibited the migration of melanoma cells without showing obvious cellular cytotoxicity at low doses. This effect correlated with the down-regulation of phosphatidylinositol 3-kinase (PI3-K) and its downstream target, Akt. Although B16-F10 cell migration was increased by the PI3-K activator through the activation of Akt, these PI3-K activator-induced phenomena were attenuated by capsaicin. Moreover, capsaicin was found to significantly inhibit Rac1 activity in a pull-down assay. These results demonstrate that capsaicin inhibits the migration of B16-F10 cells through the inhibition of the PI3-K/Akt/Rac1 signal pathway. The present investigation suggests that capsaicin targets PI3-K/Akt/Rac1-mediated cellular events in B16-F10 melanoma cells. Consequently, capsaicin administration should be considered an effective approach for the suppression of invasion and metastasis in malignant melanoma chemotherapy. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 G704-000088.2008.40.5.004 http://kmbase.medric.or.kr/Main.aspx?d=KMBASE&m=VIEW&i=0620920080400050486 |
ISSN: | 1226-3613 2092-6413 |
DOI: | 10.3858/emm.2008.40.5.486 |